Alpa Laboratories Limited (BOM:532878)
India · Delayed Price · Currency is INR 63.03
+0.83 (1.33%)
At close: Aug 21, 2026
Alpa Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,320 | 978 | 2,180 | 1,752 | 1,132 | 1,467 | |
Market Cap Growth | -36.46% | -55.15% | 24.44% | 54.74% | -22.81% | 93.61% |
Enterprise Value | -33 | -412 | 1,111 | 747 | 569 | 908 |
Last Close Price | 63.03 | 46.25 | 104.12 | 83.41 | 53.78 | 69.50 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 31.27 | 6.51 | 11.18 | 10.44 | 9.00 | 10.41 |
PS Ratio | 1.19 | 0.92 | 1.94 | 1.61 | 1.22 | 1.31 |
PB Ratio | 0.71 | 0.53 | 1.27 | 1.15 | 0.84 | 1.21 |
P/TBV Ratio | 0.71 | 0.53 | 1.27 | 1.15 | 0.84 | 1.21 |
P/FCF Ratio | 22.02 | 16.30 | 31.42 | - | 14.55 | 18.92 |
P/OCF Ratio | 13.27 | 9.82 | 11.90 | 48.01 | 12.71 | 14.75 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | - | - | 0.99 | 0.69 | 0.61 | 0.81 |
EV/EBITDA Ratio | - | - | 23.62 | 8.67 | 7.03 | 8.51 |
EV/EBIT Ratio | - | - | 44.42 | 11.22 | 8.42 | 10.08 |
EV/FCF Ratio | - | - | 16.01 | - | 7.32 | 11.71 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0 | 0.04 | 0.02 | 0.05 |
Debt / EBITDA Ratio | - | 0.76 | 0.01 | 0.61 | 0.28 | 0.55 |
Debt / FCF Ratio | - | 0.42 | 0.01 | - | 0.30 | 0.76 |
Net Debt / Equity Ratio | -0.73 | -0.73 | -0.66 | -0.58 | -0.58 | -0.53 |
Net Debt / EBITDA Ratio | 18.14 | -41.14 | -23.96 | -10.17 | -9.71 | -6.04 |
Net Debt / FCF Ratio | - | -22.57 | -16.24 | 32.01 | -10.10 | -8.31 |
Asset Turnover | - | 0.46 | 0.56 | 0.62 | 0.58 | 0.76 |
Inventory Turnover | - | 4.80 | 4.86 | 5.67 | 4.39 | 4.75 |
Quick Ratio | - | 3.46 | 3.52 | 4.85 | 4.31 | 3.60 |
Current Ratio | - | 4.01 | 4.12 | 5.74 | 5.03 | 4.40 |
Return on Equity (ROE) | - | 8.39% | 12.06% | 11.71% | 9.82% | 12.29% |
Return on Assets (ROA) | - | 0.32% | 0.77% | 2.38% | 2.62% | 3.81% |
Return on Invested Capital (ROIC) | -13.37% | 1.97% | 3.09% | 8.97% | 9.45% | 10.58% |
Return on Capital Employed (ROCE) | - | 0.60% | 1.40% | 4.30% | 4.90% | 7.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.20% | 15.35% | 8.95% | 9.58% | 11.12% | 9.61% |
FCF Yield | 4.54% | 6.13% | 3.18% | -1.56% | 6.87% | 5.28% |
Buyback Yield / Dilution | 4.17% | - | - | - | - | 0.00% |